AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 6.43 |
Market Cap | 108.34M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 0.57 |
PE Ratio (ttm) | 11.6 |
Forward PE | n/a |
Analyst | Strong Buy |
Ask | 6.87 |
Volume | 248,859 |
Avg. Volume (20D) | 211,685 |
Open | 6.40 |
Previous Close | 6.38 |
Day's Range | 6.40 - 6.87 |
52-Week Range | 2.61 - 9.33 |
Beta | undefined |
About SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and s...
Analyst Forecast
According to 2 analyst ratings, the average rating for SRTS stock is "Strong Buy." The 12-month stock price forecast is $12.5, which is an increase of 89.11% from the latest price.
Next Earnings Release
Analysts project revenue of $10.31M, reflecting a -17.95% YoY shrinking and earnings per share of 0.11, making a -57.69% decrease YoY.
2 months ago · seekingalpha.com
Sensus Healthcare: Q3 Results Showed That The Stock Is UndervaluedSensus Healthcare's Q3 results exceeded expectations with 127% YoY revenue growth and EPS of $0.07, showcasing strong demand recovery and effective management strategies. The Fair Deal Agreement and n...
2 months ago · seekingalpha.com
Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call TranscriptSensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript